Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 5:58 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 360 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Pharmacist intervention Clear all

Conditions: Diabetes Mellitus, Type 2
Interventions: mHealth for Diabetes Adherence Support; Behavioral
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 21 Years to 75 Years
Enrollment: 221 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2022
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: COVID-19
Interventions: COVID Booster text messages; Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 520,000 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Opioid Use Disorder, Overdose
Interventions: Pharmacist Narcan Training, BIRT, SMC, Substance Use Counselor Narcan Training; Behavioral
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years and older
Enrollment: 267 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Ebola Virus Disease
Interventions: Recombinant Vesicular Stomatitis Vaccine for Ebola (rVSV∆G-ZEBOV-GP), Deuterium Labeled Water; Biological · Other
Lead sponsor: Emory University; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 2
States / cities: Decatur, Georgia • St Louis, Missouri

Conditions: Adverse Drug Event, Drug Drug Interaction, Pharmacogenomics, Elderly
Interventions: Pharmacogenomic Testing; Other
Lead sponsor: Tabula Rasa HealthCare; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Orlando, Florida

Conditions: Bacteremia
Interventions: No Intervention; Other
Lead sponsor: Methodist Health System; Other
Eligibility: 18 Years and older
Enrollment: 146 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Geriatric Assessment, Frail Elderly, Skilled Nursing Facilities, Patient-centered Care
Interventions: Deprescribing intervention; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Human Papillomavirus Vaccines
Interventions: Community Pharmacists Vaccinating Against Cancer; Behavioral
Lead sponsor: Arizona State University; Other
Eligibility: 18 Years to 85 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Mesa, Arizona

Conditions: Cardiovascular Diseases, Lung Diseases
Interventions: Minimal intervention, Enhanced Intervention; Behavioral
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years and older
Enrollment: 954 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Hyperlipidemia, Diabetes, Hypertension
Interventions: Glucose and lipids, Glycosylated Hemoglobin A1c, Blood Pressure and Heart Rate, Body mass index, Waist and Hip circumference, Comprehensive Medication Management; Device · Behavioral
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 64 Years
Enrollment: 121 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Duluth, Minnesota

Conditions: Prediabetic State
Interventions: Shared decision-making with pharmacists, Standard care from primary care providers; Behavioral · Other
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 521 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2019
U.S. locations: 20
States / cities: Burbank, California • Los Angeles, California • Pacific Palisades, California + 2 more

Conditions: Smoking Cessation
Interventions: Pharmacist Intervention; Behavioral
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years to 100 Years
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Health Services, Comorbidity, Primary Health Care
Interventions: SUMMIT intervention, Enhanced usual care; Other
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2021
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Mild Cognitive Impairment
Interventions: Memory XL, placebo; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 55 Years to 85 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 2
States / cities: Oklahoma City, Oklahoma

Conditions: Polycythemia Vera
Interventions: Standardized progress note; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: Not listed
Enrollment: 32 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Hypertension, Cardiovascular Diseases, Vascular Diseases
Interventions: HTN Educational Video, Visual Echocardiogram Image Clips, Mobile Health and Remote BP monitoring, Post-Acute Care HTN Transition consultation (PACHT-c); Other
Lead sponsor: University of Illinois Chicago; Other
Eligibility: 18 Years to 75 Years
Enrollment: 574 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Solid Tumor, Hematologic Malignancy
Interventions: Multilevel Adherence Intervention; Behavioral
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 21 Years and older
Enrollment: 160 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Hypertension, Diabetes, Hypercholesterolemia
Interventions: education intervention; Behavioral
Lead sponsor: Durham VA Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Vaccine Hesitancy
Interventions: MOtivational interviewing Tool to Improve Vaccine AdherencE (MOTIVE); Other
Lead sponsor: Cedarville University; Other
Eligibility: 0 Years to 6 Years
Enrollment: 4,191 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Springfield, Ohio

Conditions: Hyperlipidemia, Coronary Artery Disease
Interventions: Pharmacist Intervention in lipid therapy; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Concord, North Carolina

Conditions: Heart Failure
Interventions: Pharmacist Heart failure MTM training, Patient Heart failure MTM intervention; Behavioral
Lead sponsor: Providence VA Medical Center; Federal
Eligibility: 18 Years and older
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 2
States / cities: Providence, Rhode Island

Conditions: Health Related Social Needs (HRSN), Pharmacy, Medication Reconciliation
Interventions: Intervention; Other
Lead sponsor: State University of New York at Buffalo; Other
Eligibility: 18 Years and older
Enrollment: 58 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Buffalo, New York

Conditions: Chronic Pain
Interventions: Pharmacogenetic Testing, Pharmacist Consultation Note, Delayed pharmacogenetic testing; Genetic · Other
Lead sponsor: Medstar Health Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 315 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Medication Reconciliation
Interventions: New technology - PAML; Procedure
Lead sponsor: Brigham and Women's Hospital; Other
Eligibility: 18 Years and older
Enrollment: 322 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: Boston, Massachusetts

Search by objective public record fields.

mHealth for Diabetes Adherence Support

Message From Local Pharmacy Team

Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)

Immunology of Ebola Vaccine

Implementation of a Pharmacist-led Pharmacogenomic Clinical Service

Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge

Drug Reduction in Older Patients: The DROP Trial

Community Pharmacists Vaccinate Against Cancer

Expanding the Role of Pharmacists in Treating Persons With Cardiovascular or Lung Diseases

Point-of-Care Testing (POCT) Detection and Management of Metabolic Syndrome in Patients With Mental Illness

A Pharmacist-Coordinated Implementation of the Diabetes Prevention Program

Pharmacist Intervention to Improve Smoking Cessation

Ambulatory ICU Study for Medically and Socially Complex Patients

MemoryXL Effects on Mild Cognitive Impairment Patients

Standardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative

Targeting of UnControlled Hypertension in Emergency Department

Implementation of an Oral Chemotherapy Adherence Intervention

Medication Adherence With Polyglot Meducation

Motivational Interviewing and Vaccine Hesitancy in Children

Evaluation of Pharmacist Interventions in Lipid Management for Secondary Prevention

Community Pharmacy Medication Therapy Management for Heart Failure

Pharmacist-Led SDoH Screening Intervention During Transitions of Care in an Acute Care Setting

Pharmacogenomics Applied to Chronic Pain Treatment in Primary Care

Implementation and Evaluation of a Medical Reconciliation Protocol at Brigham and Women's Hospital